iShares MSCI South Africa ETF vs 22nd Century Group Inc — how do they compare? iShares MSCI South Africa ETF trades at $68.53, while 22nd Century Group Inc trades at $4.44 (market cap $1.52M). The key difference: iShares MSCI South Africa ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| EZA | XXII | |
|---|---|---|
Sector | Broad Market / Factor | Technology |
52-Week High | $81.60 | $801.00 |
52-Week Low | $56.57 | $3.72 |
Market Cap | — | $1.52M |
Enterprise Value | — | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
EZA trades at $68.33, down 2.01% today, with a bullish technical bias from moving averages but bearish oscillators. Key support is at $68 and resistance at $70. The company has a dividend scheduled for June 2026, but financial ratios like P/E and P/S are not provided in the data.
Outlook is mixed: technical strength contrasts with macroeconomic headwinds highlighted in recent news. Risks include exposure to South African sectors sensitive to interest rates and commodities. Investment appeal hinges on navigating these challenges amid a bullish trend signal.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Trailing returns across standard periods
EZA is a country-specific ETF that tracks the South African equity market. It provides exposure to large and mid-cap companies across key sectors like materials and financials, with top holdings such as AngloGold Ashanti and Naspers.
Read more on EZA →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →